MJA
MJA InSight
MJA Careers
Letters

A to X: the problem of categorisation of drugs in pregnancy — an Australian perspective

Debra S Kennedy
Med J Aust 2012; 196 (3): 172-173.
doi:
10.5694/mja11.11541

In reply: As a practising physician, Morton clearly understands the issues faced by prescribers and consumers regarding drug categorisation in pregnancy.1 Currently, the Therapeutic Goods Administration provides no references for the data on which it bases its drug categorisations for pregnancy.

Debra S Kennedy, Director of MotherSafe
Royal Hospital for Women, Sydney, NSW.
Article References: 
Reference Text: 
Kennedy DS. A to X: the problem of categorisation of drugs in pregnancy — an Australian perspective. Med J Aust 2011; 195: 572-574.
Reference Order: 
1
PubMed ID: 
22106996
Reference Text: 
Kweder SL. Drugs and biologics in pregnancy and breastfeeding: FDA in the 21st century. Birth Defects Res A Clin Mol Teratol 2008; 82: 605-609.
Reference Order: 
2
PubMed ID: 
18704917
Reference Text: 
US Food and Drug Administration. List of pregnancy exposure registries. http://www.fda.gov/ScienceResearch/SpecialTopics/WomensHealthResearch/ucm134848.htm (accessed Dec 2011).
Reference Order: 
3

The full contents of this page are only available to subscribers.